XML 33 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2021
Reconciliation of Numerators and Denominators used in Computing Basic and Diluted Net Income Per Share
The following is a reconciliation of the numerators and denominators used in computing basic and diluted net income per share:
 
    
Three Months Ended
    
Six Months Ended
 
    
June 30,
2021
    
June 30,
2020
    
June 30,
2021
    
June 30,
2020
 
Net income (loss)
   $ (2,227,499    $ (4,098,623    $ (5,947,717    $ (6,996,598
    
 
 
    
 
 
    
 
 
    
 
 
 
         
Numerator, basic and diluted net income (loss) available to stockholders
   $ (2,227,499    $ (4,098,623    $ (5,947,717    $ (6,996,598
    
 
 
    
 
 
    
 
 
    
 
 
 
         
Denominator:
                                   
Shares used in computation – basic:
                                   
Weighted average common shares outstanding
     13,023,330        9,542,449        12,818,266        9,530,056  
    
 
 
    
 
 
    
 
 
    
 
 
 
         
Common shares outstanding for basic
     13,023,330        9,542,449        12,818,266        9,530,056  
    
 
 
    
 
 
    
 
 
    
 
 
 
         
Shares used in computation – diluted:
                                   
Common shares outstanding for basic
     13,023,330        9,542,449        12,818,266        9,530,056  
    
 
 
    
 
 
    
 
 
    
 
 
 
Shares used in computing diluted net income per share
     13,023,330        9,542,449        12,818,266        9,530,056  
    
 
 
    
 
 
    
 
 
    
 
 
 
         
Net (loss) per share – basic
   $ (0.17    $ (0.43    $ (0.46    $ (0.73
Net (loss) per share – diluted
   $ (0.17    $ (0.43    $ (0.46    $ (0.73
In the Money Potential Common Shares [Member]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The potential common shares in the following tables represent potential common shares calculated using the
if-converted
method from outstanding options, stock awards and warrants that were excluded from the calculation of diluted EPS:
 
    
Three Months Ended
    
Six Months Ended
 
    
June 30,

2021
    
June 30,

2020
    
June 30,

2021
    
June 30,

2020
 
Average market price during the period
   $ 6.55      $ 4.27      $ 6.91      $ 4.04  
         
In the money potential common shares from options excluded
     22,493        22,493        22,493        22,493  
In the money potential common shares from warrants excluded
     2,781,314        633,784        2,781,314        633,784  
Out of Money Potential Common Shares [Member]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Potential common shares from out of the money options and warrants were also excluded from the computation of diluted EPS because calculation of the associated potential common shares has an anti-dilutive effect on EPS. The following table lists options and warrants that were excluded from diluted EPS:
    
Three Months Ended
    
Six Months Ended
 
Per share
exercise price
  
June 30,
2021
    
June 30,
2020
    
June 30,
2021
    
June 30,
2020
 
Out of the money options excluded:
 
        
$12.48
     136,833      136,833      136,833      136,833
$12.84
     4,167        4,167        4,167        4,167  
$26.40
     75,158        75,158        75,158        75,158  
Out-of-the-money
warrants excluded:
 
        
$7.16
     700,000      700,000      700,000      700,000
  
 
 
    
 
 
    
 
 
    
 
 
 
Total excluded
     916,158        916,158        916,158        916,158  
  
 
 
    
 
 
    
 
 
    
 
 
 
Unvested Restricted Stock Awards Excluded from EPS [Member]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The common shares relating to our unvested restricted stock awards that were excluded from potential common shares in the earning per share calculation due to having an anti-dilutive effect are:
 
    
Three Months Ended
    
Six Months Ended
 
    
June 30,
2021
    
June 30,
2020
    
June 30,
2021
    
June 30,
2020
 
Potential common shares from unvested restricted stock awards excluded from EPS
     497,350        343,353        497,350        343,353